|
1
|
Kong Y, Huo JL, Xu W, Xiong J, Li YM and
Wu WT: A novel anti-platelet aggregation tripeptide from
Agkistrodon acutus venom: Isolation and characterization. Toxicon.
54:103–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng J, Chen T, Zhou M and Shaw C: Cloning
of cDNAs and molecular characterisation of C-type lectin-like
proteins from snake venoms. Toxicon. 60:1363–1369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang W, Ma T, Su X, Qiu P and Yan G:
Enzymatic activities and functional characterization of a novel
recombinant snake venom proteinase from Agkistrodon acutus.
Biochimie. 91:277–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo S, Wang R, Jiang W, Lin X, Qiu P and
Yan G: A novel recombinant snake venom metalloproteinase from
Agkistrodon acutus protects against taurocholate induced severe
acute pancreatitis in rats. Biochimie. 92:1354–1361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Villalta M, Pla D, Yang SL, Sanz L, Segura
A, Vargas M, Chen PY, Herrera M, Estrada R, Cheng YF, et al: Snake
venomics and antivenomics of Protobothrops mucrosquamatus and
Viridovipera stejnegeri from Taiwan: Keys to understand the
variable immune response in horses. J Proteomics. 75:5628–5645.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Markland FS and Swenson S: Snake venom
metalloproteinases. Toxicon. 62:3–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Azofeifa-Cordero G, Arce-Estrada V,
Flores-Díaz M and Alape-Girón A: Immunization with cDNA of a novel
P-III type metalloproteinase from the rattlesnake Crotalus durissus
durissus elicits antibodies which neutralize 69% of the hemorrhage
induced by the whole venom. Toxicon. 52:302–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stas P and Lasters I: Immunogenicity of
therapeutic antibodies. Med Sci (Paris). 25:1070–1077. 2009.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chames P and Baty D: The future of
antibody fragments, made of a single immunoglobulin domain. Med Sci
(Paris). 25:1159–1162. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cabezas S, Rojas G, Pavon A, Alvarez M,
Pupo M, Guillen G and Guzman MG: Selection of phage-displayed human
antibody fragments on Dengue virus particles captured by a
monoclonal antibody: Application to the four serotypes. J Virol
Methods. 147:235–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang KH, Yusoff K and Tan WS: Display of
hepatitis B virus PreS1 peptide on bacteriophage T7 and its
potential in gene delivery into HepG2 cells. J Virol Methods.
159:194–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sblattero D and Bradbury A: A definitive
set of oligonucleotide primers for amplifying human V regions.
Immunotechnology. 3:271–278. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haidaris CG, Malone J, Sherrill LA, Bliss
JM, Gaspari AA, Insel RA and Sullivan MA: Recombinant human
antibody single chain variable fragments reactive with Candida
albicans surface antigens. J Immunol Methods. 257:185–202. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Zheng C, Liu Y, Zheng H and Wang
Z: Construction of multiform scFv antibodies using linker peptide.
Genet J Genomics. 35:313–316. 2008. View Article : Google Scholar
|
|
15
|
Bhatia S, Gangil R, Gupta DS, Sood R,
Pradhan HK and Dubey SC: Single-chain fragment variable antibody
against the capsid protein of bovine immunodeficiency virus and its
use in ELISA. J Virol Methods. 167:68–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Studier WF: Protein production by
auto-induction in high-density shaking cultures. Protein Expr
Purif. 41:207–234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Monnier PP, Vigouroux RJ and Tassew NG: In
vivo applications of single chain Fv (Variable Domain) (scFv)
fragments. Antibodies. 2:193–208. 2013. View Article : Google Scholar
|
|
18
|
Sun D, Shi H, Chen J, Shi D, Zhu Q, Zhang
H, Liu S, Wang Y, Qiu H and Feng L: Generation of a mouse scFv
library specific for porcine aminopeptidase N using the T7 phage
display system. J Virol Methods. 182:99–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sheets MD, Amersdorfer P, Finnern R,
Sargent P, Lindqvist E, Schier R, Hemingsen G, Wong C, Gerhart JC
and Marks JD: Efficient construction of a large nonimmune phage
antibody library: The production of high-affinity human
single-chain antibodies to protein antigens. Proc Natl Acad Sci
USA. 95:6157–6162. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamberski JA, Thompson NE and Burgess RR:
Expression and puriWcation of a single-chain variable fragment
antibody derived from a polyol-responsive monoclonal antibody.
Protein Expr Purif. 47:82–92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan L, Zeng L, Chen L, Huang Q, Li S, Lu
Y, Li Y, Cheng J and Lu X: Expression, purification, and refolding
of a novel immunotoxin containing humanized single-chain fragment
variable antibody against CTLA4 and the N-terminal fragment of
human perforin. Protein Expr Purif. 48:307–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heo MA, Kim SH, Kim SY, Kim YJ, Chung J,
Oh MK and Lee SG: Functional expression of single-chain variable
fragment antibody against c-Met in the cytoplasm of Escherichia
coli. Protein Expr Purif. 47:203–209. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Q, Chan YW, Lee SS and Cheung WT:
One-step expression and purification of single-chain variable
antibody fragment using an improved hexahistidine tag phagemid
vector. Protein Expr Purif. 68:190–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang T, Yang L, Chai W, Li R, Xie J and
Niu B: A strategy for high-level expression of a single-chain
variable fragment against TNFα by subcloning antibody variable
regions from the phage display vector pCANTAB 5E into pBV220.
Protein Expr Purif. 76:109–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bu D, Zhou Y, Tang J, Jing F and Zhang W:
Expression and purification of a novel therapeutic single-chain
variable fragment antibody against BNP from inclusion bodies of
Escherichia coli. Protein Expr Purif. 92:203–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deckert PM: Current constructs and targets
in clinical development for antibody-based cancer therapy. Curr
Drug Targets. 10:158–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
